Human Recombinant KLK13 protein, His Tag-1 (V2LY-0526-LY5122)

Name: Human Recombinant KLK13 protein, His Tag-1
SKU: V2LY-0526-LY5122
Rating: 5 (1 reviews)

See all KLK13 antibodies

Compare Online Inquiry

Datasheet

SDS

Request for COA

Datasheet Target References Q & As Review & reward Protocols Associated Products

Basic Information

Expressed Host

HEK293 Cells

Protein Species

Human

Tag

His Tag

Protein Construction

This product is Human Recombinant KLK13 protein, His Tag consist of Amino Acid: 1-262 and predicts a molecular mass of 28.4 kDa.

Molecule Mass

28.4 kDa

Verified

HPLC

Sequence

Amino Acid: 1-262

Species

Human

Formulations & Storage [For reference only, actual COA shall prevail!]

Purity

≥95% as determined by SDS-PAGE. ≥95% as determined by SEC-HPLC.

Endotoxin

Please contact us for more information.

Format

Lyophilized

Reconstitution

Allow the vial and reconstitution buffer to equilibrate to room temperature. Briefly centrifuge or tap down the vial to ensure that all lyophilized powder is collected at the bottom of the vial. For the reconstitution of this product, we recommend adding PBS or sterile water to achieve a final antibody concentration of 1 mg/mL. Allow the vial to reconstitute for 10-15 minutes at room temperature with gentle agitation. Avoid vigorous shaking that can cause foaming and antibody denaturation. Aliquot into volumes based on your experiment and store liquid protein at -20°C or -80°C for long time.

Buffer

Lyophilized from sterile PBS

Preservative

None

Storage

Samples are stable for up to twelve months from date of receipt at -20°C to -80°C. Store it under sterile conditions at -20°C to -80°C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

More Infomation

Target

Full Name

kallikrein-related peptidase 13

Biological Process

Protein processingIEA:Ensembl
Proteolysis1 PublicationNAS:UniProtKB

Cellular Location

Secreted

Sumiya, R., Yamada, K., Hagiwara, T., Nagasaka, S., Miyazaki, H., Igari, T., & Kawamura, Y. I. (2023). Kallikrein-related peptidase 13 expression and clinicopathological features in lung squamous cell carcinoma. Molecular and Clinical Oncology, 19(2), 1-7.

Shimomura, A., Hagiwara, T., Yamada, K., Yokoi, C., Terayama, M., Nohara, K., ... & Kawamura, Y. I. (2023). Induction of kallikrein-related peptidase 13 and TET2/3 by anticancer drugs and poor prognosis of patients with esophageal squamous cell carcinoma after preoperative treatment. Annals of Surgical Oncology, 1-11.

Gruba, N., Rachubik, P., Piwkowska, A., & Lesner, A. (2021). Analysis of urinary kallikrein-related peptidase 13 for monitoring bladder cancer. Biomarkers, 26(8), 770-779.

Milewska, A., Falkowski, K., Kalinska, M., Bielecka, E., Naskalska, A., Mak, P., ... & Pyrc, K. (2020). Kallikrein 13: a new player in coronaviral infections. biorxiv, 2020-03.

Milewska, A., Falkowski, K., Kulczycka, M., Bielecka, E., Naskalska, A., Mak, P., ... & Pyrc, K. (2020). Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1. Science signaling, 13(659), eaba9902.

Nohara, K., Yamada, K., Yamada, L., Hagiwara, T., Igari, T., Yokoi, C., ... & Kawamura, Y. I. (2018). Expression of kallikrein-related peptidase 13 is associated with poor prognosis in esophageal squamous cell carcinoma. General thoracic and cardiovascular surgery, 66, 351-357.

Gruba, N., Bielecka, E., Wysocka, M., Wojtysiak, A., Brzezińska-Bodal, M., Sychowska, K., ... & Lesner, A. (2019). Development of chemical tools to monitor human kallikrein 13 (KLK13) activity. International journal of molecular sciences, 20(7), 1557.

Ask a question We look forward to hearing from you.

0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Have you used Human Recombinant KLK13 protein, His Tag-1?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon

$30 eGift Card
Submit a review

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Alternative Versions

Human Recombinant KLK13 protein, His Tag (CAT#: V2LY-0526-LY5121)

Related Products

Mouse Anti-KLK13 Recombinant Antibody (10H10A2C4) (CAT#: CBMAB-K1219-LY)

Mouse Anti-KLK13 Recombinant Antibody (1G9) (CAT#: CBMAB-K1221-LY)

Mouse Anti-KLK13 Recombinant Antibody (MM0428-5X29) (CAT#: CBMAB-K1224-LY)

Rabbit Anti-KLK13 Recombinant Antibody (1) (CAT#: CBMAB-K1218-LY)

Mouse Anti-KLK13 Recombinant Antibody (14L659) (CAT#: CBMAB-K1220-LY)

Human Recombinant KLK13 protein, His Tag (CAT#: V2LY-0526-LY5121)

Isotype control

For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Request bulk or custom quote Second antibody and isotype control

Contact us

Tel: (USA)
(UK)
Fax:

Global Locations

Email:

Online Inquiry